These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19903376)

  • 1. Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome.
    Gao XR; Adhikari CM; Peng LY; Guo XG; Zhai YS; He XY; Zhang LY; Lin J; Zuo ZY
    J Pharm Pharmacol; 2009 Nov; 61(11):1505-10. PubMed ID: 19903376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
    Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another look at the results of the JUPITER trial.
    Kappagoda CT; Amsterdam EA
    Am J Cardiol; 2009 Dec; 104(11):1603-5. PubMed ID: 19932800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse.
    Totani L; Dell'Elba G; Martelli N; Di Santo A; Piccoli A; Amore C; Evangelista V
    Thromb Haemost; 2012 Jun; 107(6):1130-40. PubMed ID: 22436970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
    Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
    Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome.
    Kahraman G; Sahin T; Kilic T; Baytugan NZ; Agacdiken A; Ural E; Ural D; Komsuoglu B
    Int J Cardiol; 2007 Feb; 115(3):391-6. PubMed ID: 17218028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin resistance following pediatric cardiac surgery.
    Cholette JM; Mamikonian L; Alfieris GM; Blumberg N; Lerner NB
    Thromb Res; 2010 Sep; 126(3):200-6. PubMed ID: 20550971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.
    Muhlestein JB
    Thromb Haemost; 2010 Jan; 103(1):71-82. PubMed ID: 20062914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery.
    Arazi HC; Doiny DG; Torcivia RS; Grancelli H; Waldman SV; Nojek C; Fornari MC; Badimon JJ
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):863-7. PubMed ID: 20233808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial.
    Hovens MM; Snoep JD; Groeneveld Y; Frölich M; Tamsma JT; Huisman MV
    Diabetes Obes Metab; 2008 Aug; 10(8):668-74. PubMed ID: 18034847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
    Willerson JT; Cable G; Yeh ET;
    Tex Heart Inst J; 2009; 36(6):530-9. PubMed ID: 20069077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers.
    Cryer B; Berlin RG; Cooper SA; Hsu C; Wason S
    Clin Ther; 2005 Feb; 27(2):185-91. PubMed ID: 15811481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.